Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
55 studies found for:    Open Studies | "Muscular Dystrophy, Duchenne"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Muscular Dystrophy, Duchenne"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Double Push Acoustic Radiation Force (DP ARF) Ultrasound for Monitoring Degeneration in Duchenne Muscular Dystrophy
Condition: Muscular Dystrophy, Duchenne
Intervention:
2 Recruiting Assessment of Cardiopulmonary Function in Duchenne Muscular Dystrophy
Condition: Muscular Dystrophy, Duchenne
Interventions: Other: Magnetic Resonance Imaging (MRI);   Other: Pulmonary Function Testing (PFT);   Other: Metabolic Exercise Testing using stationary bicycle;   Other: Echocardiogram
3 Recruiting Rimeporide in Patients With Duchenne Muscular Dystrophy
Condition: Muscular Dystrophy, Duchenne
Intervention: Drug: Rimeporide
4 Not yet recruiting An Open-label Extension Study To Evaluate Safety Of PF-06252616 In Boys With Duchenne Muscular Dystrophy
Condition: Duchenne Muscular Dystrophy
Intervention: Biological: PF-06252616
5 Recruiting A Phase 2 Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of PF-06252616 in Duchenne Muscular Dystrophy
Condition: Duchenne Muscular Dystrophy
Interventions: Biological: PF-06252616;   Drug: Placebo
6 Recruiting An Extension Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD)
Condition: Duchenne Muscular Dystrophy
Interventions: Drug: Vamorolone 0.25 mg/day/day;   Drug: Vamorolone 0.75 mg/day/day;   Drug: Vamorolone 2.0 mg/day/day;   Drug: Vamorolone 6.0 mg/day/day
7 Recruiting A Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD)
Condition: Duchenne Muscular Dystrophy
Interventions: Drug: Vamorolone 0.25 mg/kg/day;   Drug: Vamorolone 0.75 mg/kg/day;   Drug: Vamorolone 2.0 mg/kg/day;   Drug: Vamorolone 6.0 mg/kg/day
8 Recruiting Study of DS-5141b in Patients With Duchenne Muscular Dystrophy
Condition: Duchenne Muscular Dystrophy
Intervention: Drug: DS-5141b
9 Not yet recruiting Analysis of a Virtual Reality Task in Patients With Duchenne Muscular Dystrophy
Condition: Duchenne Muscular Dystrophy
Interventions: Device: Acquisition on TouchScreen;   Device: Acquisition on Kinect;   Device: Acquisition on LeapMotion
10 Recruiting Observational Study of Patients With Duchenne Muscular Dystrophy Theoretically Treatable With Exon 53 Skipping
Condition: Duchenne Muscular Dystrophy
Intervention:
11 Recruiting Plus Epicatechin Duchenne Muscular Dystrophy in Non-ambulatory Adolescents
Condition: Duchenne Muscular Dystrophy
Intervention: Drug: (+)- Epicatechin
12 Recruiting Registry of Translarna (Ataluren) in Nonsense Mutation Duchenne Muscular Dystrophy
Condition: Muscular Dystrophy, Duchenne
Intervention: Drug: Translarna
13 Recruiting Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular Dystrophy
Condition: Duchenne Muscular Dystrophy
Intervention: Drug: Prednisolone
14 Not yet recruiting Validating Cardiac MRI Biomarkers and Genotype-Phenotype Correlations for DMD
Condition: Muscular Dystrophy, Duchenne
Interventions: Other: Cardiac MRI with contrast;   Other: Cardiac MRI without contrast;   Other: Blood Test;   Other: Heart Rate;   Other: Pulmonary Function Test;   Other: Genetic Testing;   Other: Repeat MRI scan
15 Recruiting Strength Training in Duchenne Muscular Dystrophy
Condition: Duchenne Muscular Dystrophy
Interventions: Procedure: Aim 2 Exercise group;   Procedure: Aim 1 Exercise Dosing;   Procedure: Aim 2 Control group
16 Recruiting Finding the Optimum Regimen for Duchenne Muscular Dystrophy
Condition: Duchenne Muscular Dystrophy
Interventions: Drug: Prednisone;   Drug: Deflazacort
17 Recruiting Transplantation of Myoblasts to Duchenne Muscular Dystrophy (DMD) Patients
Condition: Duchenne Muscular Dystrophy
Interventions: Biological: Myoblast transplantation;   Procedure: Saline injection
18 Recruiting A Phase IIa Study of TAS-205 for Duchenne Muscular Dystrophy
Condition: Duchenne Muscular Dystrophy
Interventions: Drug: TAS-205;   Drug: Placebo
19 Recruiting Therapeutic Potential for Aldosterone Inhibition in Duchenne Muscular Dystrophy
Condition: Duchenne Muscular Dystrophy
Interventions: Drug: Eplerenone;   Drug: Spironolactone
20 Recruiting Duchenne Muscular Dystrophy < 18y in Norway: Genotype/Phenotype, Growth, Puberty, Bone Health and Quality of Life.
Condition: Duchenne Muscular Dystrophy
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.